| Template-Guided 3D Molecular Pose Generation via Flow Matching and Differentiable Optimization | May 22, 2025 | Drug DesignPose Prediction | —Unverified | 0 |
| Evolutionary training-free guidance in diffusion model for 3D multi-objective molecular generation | May 16, 2025 | DenoisingDrug Design | —Unverified | 0 |
| Pharmacophore-Conditioned Diffusion Model for Ligand-Based De Novo Drug Design | May 15, 2025 | Drug DesignDrug Discovery | —Unverified | 0 |
| A 3D pocket-aware and evolutionary conserved interaction guided diffusion model for molecular optimization | May 9, 2025 | Drug Design | —Unverified | 0 |
| Enhancing Chemical Reaction and Retrosynthesis Prediction with Large Language Model and Dual-task Learning | May 5, 2025 | Drug DesignDrug Discovery | —Unverified | 0 |
| Leveraging Partial SMILES Validation Scheme for Enhanced Drug Design in Reinforcement Learning Frameworks | May 1, 2025 | Deep Reinforcement LearningDrug Design | —Unverified | 0 |
| Combining GCN Structural Learning with LLM Chemical Knowledge for or Enhanced Virtual Screening | Apr 24, 2025 | Computational EfficiencyDrug Design | —Unverified | 0 |
| Synergistic Benefits of Joint Molecule Generation and Property Prediction | Apr 23, 2025 | Drug Designmolecular representation | —Unverified | 0 |
| DrugGen enhances drug discovery with large language models and reinforcement learning | Apr 18, 2025 | Drug DesignDrug Discovery | CodeCode Available | 0 |
| How to Detect and Defeat Molecular Mirage: A Metric-Driven Benchmark for Hallucination in LLM-based Molecular Comprehension | Apr 10, 2025 | Computational EfficiencyDecoder | —Unverified | 0 |
| Interpretable Multimodal Learning for Tumor Protein-Metal Binding: Progress, Challenges, and Perspectives | Apr 4, 2025 | Drug Design | —Unverified | 0 |
| HCAF-DTA: drug-target binding affinity prediction with cross-attention fused hypergraph neural networks | Apr 2, 2025 | Drug DesignPrediction | —Unverified | 0 |
| Two for the Price of One: Integrating Large Language Models to Learn Biophysical Interactions | Mar 26, 2025 | Computational EfficiencyDrug Design | —Unverified | 0 |
| TransDiffSBDD: Causality-Aware Multi-Modal Structure-Based Drug Design | Mar 26, 2025 | Drug DesignDrug Discovery | —Unverified | 0 |
| Extracting Interpretable Logic Rules from Graph Neural Networks | Mar 25, 2025 | Drug DesignDrug Discovery | —Unverified | 0 |
| Carbonic anhydrase II simulated with a universal neural network potential | Mar 18, 2025 | Drug Design | CodeCode Available | 0 |
| Linear to Neural Networks Regression: QSPR of Drugs via Degree-Distance Indices | Mar 18, 2025 | Drug DesignDrug Discovery | —Unverified | 0 |
| GenShin:geometry-enhanced structural graph embodies binding pose can better predicting compound-protein interaction affinity | Mar 16, 2025 | Drug DesignDrug Discovery | —Unverified | 0 |
| Pretraining Generative Flow Networks with Inexpensive Rewards for Molecular Graph Generation | Mar 8, 2025 | Drug DesignGraph Generation | —Unverified | 0 |
| Integrating Protein Dynamics into Structure-Based Drug Design via Full-Atom Stochastic Flows | Mar 6, 2025 | Drug DesignDrug Discovery | —Unverified | 0 |
| Pushing the boundaries of Structure-Based Drug Design through Collaboration with Large Language Models | Mar 3, 2025 | Drug DesignDrug Discovery | —Unverified | 0 |
| Leveraging Sequence Purification for Accurate Prediction of Multiple Conformational States with AlphaFold2 | Feb 28, 2025 | Drug DesignProtein Structure Prediction | —Unverified | 0 |
| Lattice Protein Folding with Variational Annealing | Feb 28, 2025 | Combinatorial OptimizationDrug Design | —Unverified | 0 |
| Position: Graph Learning Will Lose Relevance Due To Poor Benchmarks | Feb 20, 2025 | BenchmarkingCombinatorial Optimization | —Unverified | 0 |
| Towards Efficient Molecular Property Optimization with Graph Energy Based Models | Feb 17, 2025 | Drug Design | —Unverified | 0 |